Craig-Hallum analyst Jason Kreyer maintained a Buy rating on Cardlytics (CDLX – Research Report) today and set a price target of $15.00. The company’s shares closed yesterday at $7.42.
According to TipRanks, Kreyer is a 4-star analyst with an average return of 10.1% and a 49.37% success rate. Kreyer covers the Communication Services sector, focusing on stocks such as Stagwell, Integral Ad Science, and Magnite.
Currently, the analyst consensus on Cardlytics is a Strong Buy with an average price target of $13.33.
See today’s best-performing stocks on TipRanks >>
Based on Cardlytics’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $79.01 million and a GAAP net loss of $23.97 million. In comparison, last year the company earned a revenue of $72.71 million and had a net profit of $6.27 million
Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CDLX in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cardlytics (CDLX) Company Description:
Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.
Read More on CDLX:
- Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
- Cardlytics, Inc. (CDLX) Q4 Earnings Cheat Sheet
- Cardlytics price target lowered to $10 from $12 at Craig-Hallum
- Cardlytics Announces Successful Resolution of SRS Dispute and Preliminary Fourth Quarter 2023 Results
- Cardlytics sees Q4 revenue $89M-$90M, consensus $84.7M
